(S,R,S)-AHPC-C8-NH2 (Synonyms: VH032-C8-NH2) |
| Katalog-Nr.GC39790 |
(S,R,S)-AHPC-C8-NH2 (VH032-C8-NH2) ist ein synthetisiertes E3-Ligase-Ligand-Linker-Konjugat, das den auf VH032 basierenden VHL-Liganden und einen Linker enthÄlt, der fÜr den AKT PROTAC-Abbau verwendet wird.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2341796-79-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
(S,R,S)-AHPC-C8-NH2 (VH032-C8-NH2) is a synthesized E3 ligase ligand-linker conjugate that incorporates the VH032 based VHL ligand and a linker used for AKT PROTAC degrader. (S,R,S)-AHPC-C8-NH2 is XF038-164A, example 8, extracted from patent WO2019173516A1[1].
[1]. Jian Jin, et al. Serine threonine kinase (akt) degradation / disruption compounds and methods of use. Patent WO2019173516A1.
Average Rating: 5 (Based on Reviews and 7 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *